Dawn Colburn
About Dawn Colburn
Dawn Colburn Vice President Clinical Development
Dawn Colburn serves as the Vice President of Clinical Development at Bolt Biotherapeutics, a role she assumed in 2023. She brings over two decades of experience in oncology clinical development to the company. Colburn's extensive background in leading clinical science initiatives and developing strategies for oncology programs strengthens Bolt Biotherapeutics' commitment to advancing cancer therapies.
Dawn Colburn Education and Expertise
Dawn Colburn is a board-certified oncology pharmacist. She received a Doctor of Pharmacy (Pharm.D.) from the University of California, San Francisco, and holds a Bachelor of Science (B.S.) in biochemistry from the University of California, Davis. Her training and certification underpin her expertise in oncology clinical development, enabling her to contribute significantly to various oncology drug development programs.
Dawn Colburn Background in Oncology Clinical Development
Dawn Colburn has a profound background in oncology clinical development. She previously served as Vice President of Clinical Science at both Agenus and Arcus Biosciences, where she built and led the clinical science organization and developed strategies for non-small cell lung cancer. Her tenure at Genentech, spanning over 15 years, included participation in global filings for the Erivedge, Zelboraf, and Cotellic programs, as well as taking on the international development leadership for the Zelboraf/Cotellic programs in melanoma.
Dawn Colburn Achievements in Oncology
Dawn Colburn has contributed to several significant oncology drug development programs. At Genentech, she worked on global filings for Erivedge, Zelboraf, and Cotellic. She took on international development leadership for the Zelboraf/Cotellic programs in melanoma and was involved in research on Tecentriq and Anti-TIGIT for hematologic malignancies. These roles highlight her impactful contributions to the development of treatments for various types of cancers.
Dawn Colburn Oncology Pharmacist Experience
Before transitioning into clinical development roles, Dawn Colburn practiced as an Oncology Clinical Pharmacist for the leukemia service at MD Anderson Cancer Center. This experience provided her with direct patient care insights and a solid foundation in clinical pharmacology, further enhancing her capabilities in oncology drug development. Her board certification in oncology pharmacy attests to her specialized knowledge and commitment to the field.